T cells is accompanied by a progressive loss of their proliferative capacity. Acquisition of a specific cellular phenotype results from the expression of subsets of genes activated by specific combinations of ubiquitous and lineagerestricted transcription factors. Whether these factors are also involved in the proliferative potential of lineage-restricted cells has not been well documented. Concurrent expression of the same combination of transacting factors in both transcriptional regulation of specific genes and reduced cell proliferation would suggest a linkage between these two phenomena.
Among the transcription factors that are expressed in hematopoietic cells, the GATA proteins form a small family whose members share a common DNA binding sequence, WGATAR ( W = A or T, R = A or G). The DNA binding properties of these proteins are mediated by two cysteine type zinc fingers that are highly conserved among the GATA family. The other domains of the GATA proteins have poor homology. In humans and mice, three members of this family, GATA-I, GATA-2, and GATA-3, are expressed in the hematopoietic cells. GATA-2 is broadly expressed throughout hematopoiesis, whereas GATA-I and GATA-3 gene expression is restricted to the erythroid, megakaryocytic and mast cell lineages, and to the T-lymphocyte lineage, respectively. ' The pivotal role of GATA-1 in terminal erythroid differentiation has been shown by gene targeting experiments. Mutant embryonic stem (ES) cells lacking GATA-1 do not contribute to erythropoiesis in chimeric mice. In vitro, GATA-1 -ES cells differentiate into erythroid progenitors that give rise to colonies in which cells fail to mature beyond the proerythroblast stage and subsequently die. Surprisingly, these cells express normal levels of mRNA for genes thought to be specifically transactivated by GATA-1. The overexpression of GATA-2 "A, also observed in these cells, suggests a functional but limited redundancy between GATA-2 and GATA-1. [2] [3] [4] The transcriptional regulation of genes linked to terminal erythroid differentiation is now well documented; however, the genetic mechanisms by which erythroid differentiation is associated with a restricted cell proliferative capacity is 1 -expressing fibroblasts failed to accumulate in the GO/GI phases but did not become serum independent. GATA-1-expressing fibroblasts expressed D1, A, and B1 cyclin mRNAs under conditions of serum starvation or at confluence, whereas these cyclin mRNAs were downregulated in the parental NIH3T3 cells cultured under the same conditions. Moreover, these effects of GATA-1 expression on proliferation were not limited to NIH3T3 cells, since different clones of hGATA-1 virus-infected FDCP-1 cells, a murine interleukin-3-dependent hematopoietic cell line, had a slower growth rate than control cells. Based on these data, we hypothesize that GATA-1 plays a role in the regulation of the cell cycle during terminal erythroid differentiation. 0 1996 by The American Society of Hematology.
not well understood. A potential role of GATA-1 in the link between proliferation and terminal maturation can be hypothesized since a relationship has been described between initiation or abrogation of the expression of GATA-1 depending on the hematopoietic lineage, and progression through the cell cycle.' However, no function for GATA-1 in the cell cycle has been described.
The present work was aimed at investigating whether GATA-1, apart from its transactivating function on erythroid genes, may modify cell proliferative capacities. Ectopic expression of GATA-1 in murine NIH 3T3 fibroblasts was obtained by introducing the human GATA-1 (hGATA-1) coding sequence by retroviral infection. We showed that hGATA-1 did not transactivate erythroid-specific gene expression in fibroblasts but reduced their growth rate by prolonging S phase, and altered their proliferative response to serum growth factors. hGATA-1 expression in FDCP-1 cells (a murine interleukin-3 [IL-31 -dependent hematopoietic cell line6), also has a negative effect on cellular proliferation.
MATERIALS AND METHODS

Retroviral Vectors and Producer Cells
The retroviral vector pBT Zen hGATA-1 SVNeo was constructed by inserting a 1.5-kb DNA fragment containing the hGATA-1 coding sequence as well as 120 bp of the flanking 5' untranslated region and 60 bp of the 3' untranslated region, into the Xho I site of the pBT Zen SVNeo vector (Fig 1A) . This vector is identical to the J Zen 2 SV40 Ne0 vector' except that the 3.9-kb Sal I-Sca I fragment The retrovirus-producing cell lines were obtained by transfecting the pBT Zen hGATA-1 SVNeo or the pBT Zen SVNeo plasmids into the Gp+E86 packaging cell line8 using the calcium phosphate precipitation technique. Stable transfectants were selected using 1 mg/mL geneticin (G418; GIBCO-BRL, Paisley, Scotland). The producer clones were amplified and cultured in a medium (a-MEM; GIBCO, Paisley, Scotland) supplemented with 10% fetal calf serum (FCS, GIBCO) and maintained in 0.5 mg/mL G418.
Retroviral-Producing Cell Lines
Viral Titers
Viral production of Gp+E hGATA-1 or Gp+E Neo cells was tested by titration on NlH3T3 cells. Equal numbers of NIH3T3 cells were seeded and then infected by various quantities of supernatant from subconfluent producing cells. The next day, cells were diluted (1:30) and allowed to grow for 2 weeks in the presence of G418 at 1 mglmL. The retroviral titer was estimated as the number of G418-resistant clones.
Transfection and Chloramphenicol Acetyl Transferase (CAT) Assays in the Retroviral-Producing Cell Lines
Transfection of the Gp+E hGATA-1 and Gp+E Neo producing cell lines was performed by the calcium phosphate precipitation method using 10 mg of the reporter gene plasmid and 2 mg of the Rous Sarcoma virus (RSV)/luciferase plasmid. Forty-eight hours after transfection, the cells were obtained and CAT activity was assayed as described' using quantities of extract with identical luciferase activity.
Retrovirus-Infected NIH 3T3 Cell Lines
Several clones of hGATA-I or Neo virus-infected NIH3T3 cells were isolated and expanded in a-MEM supplemented by 10% FCS in the presence of 0.5 mg/mL (3418. Four hGATA-I and Neo clones were further studied.
DNA and RNA Analysis
Ten micrograms of genomic DNA, prepared as described,'" was digested with BglII before fractionation by electro-
Southern blots.
phoresis through a 1% agarose gel and transferred onto a Hybond N membrane (Amersham, Les Ullis, France).
Four to ten micrograms of total RNA, prepared as described," was fractionated on a 1.2% agarose-formaldehyde gel and transferred onto Hybond N membrane.
The probes used for analysis were a 1.3-kb Neo cDNA fragment, a 1.3-kb murine cyclin D1, a 0.45-kb human cyclin A, and a 1.5-kb murine cyclin B1 cDNA fragment. All probes were labeled with a '*P dCTP using the multiprime labeling kit (Amersham).
Electrophoretic Mobility Shift Assay
Nuclear extracts were prepared as described" from exponentially growing NIH3T3-infected cells. Electrophoretic mobility shift assays were performed using the 5' end-labeled double-stranded oligonucleotide 5' ATGGGCCnATCTCTTTACC 3' (coding strand), corresponding to the GATA binding site located at -70 in the erythroid porphobilinogen deaminase (PBGD) gene pr~moter.'~ For the supershift assays, a polyclonal rabbit antiserum against hGATA-I was kindly provided by G. Uzan (INSERM U 217, Grenoble. France).
Cloning ESJiciency
Five hundred cells of each tested cell line were seeded in duplicate in 100-mm diameter culture Petri dishes in the presence of G418 at 0.5 mg/mL in a-MEM supplemented with 10% FCS unless otherwise indicated. After 12 or 19 days of culture, cell clones were stained with Giemsa and counted.
Colorimetric MTT Assay
On day 0, cells from the different clones were seeded in triplicate in 96-well plates at a concentration of 5 X lo3 cellslwell or 2 X IO3 cellslwell. Twenty-four, 48, and 72 hours after seeding, an M7T 5) . respectively are indicated. The other hybridizing fragments corresponded to the 3' proviral integration site fragments characteristic of each clone (lanes 2 to 5 correspond to NIHlNeo clones A, B, C, and D, respectively, while lanes 7 to 10 correspond to NIHlhGATA-1 clones 1,2,3, and 4, respactively). Lanes 1 and 6 correspond to the Neo retrovirus and the hGATA-1 retrovirus-producing clones, respectively. They both exhibited at least three proviral integration sites. IC) Northern blot analysis of NIHlhGATA-1 and NIH/Neo clones. Four milligrams of total RNA from the different clones was electrophoresed on a formaldehyde-agarose gel, transferred onto a Hybond N membrane, UV-fixed, and hybridized with a Neo probe. Lanes 1 to 5 show the RNAs expected from Neo provirus transcription and corresponded to the Neo retrovirus-producing cell line (1) and the NlHlNeo clones A, B, C, and D (2 to 5, respectively). Lanes 6 to 10 correspond to hGATA-1 retrovirus-producing cell line (6) and NlH/ hGATA-1 clones 1,2,3, and 4 (7 to 10, respectively). (Dl Electrophoretic mobility shift assay. Nuclear extracts from the clones indicated above the gel were incubated in the presence of a 5' end-labeled doublcstranded oligonucleotide corresponding to the -70 porphobilinogen deaminase 1PBGD) GATA binding site, and electrophoresed on a 4% polyacrylamide gel. The free probe, the bound hGATA-1 complex, and the antibody-hGATA-1-probe complex are indicated. For each clone, lanes designated a correspond to the nuclear extract alone, lanes designated b to the nuclear extract preincubated with a preimmune serum, and lanes designated c to the nuclear extract preincubated with the anti-hGATA-1 anti-serum. NIHlhGATA-1 clone 4 cells were used for the experiment shown in the right part of the figure. (E) CAT assay. The Gp+E hGATA-1 and the Gp+E NE0 (controll-producing cell lines were transiently cotransfected with a construct encoding CAT transcriptionally driven by either the GATA-1 transactivatable glycophorin B promoter (GPBI or the mutated GPB promoter ImGPB), devoid of its GATA-1 binding site, and the RSVlluciferase plasmid. Cellular extracts were prepared 48 hours after transfection and subsequently assayed for CAT activities, using amounts of extracts containing identical luciferase activity. 
Frequency of Labeled Mitoses
Asynchronous subconfluent cells were labeled with tritiated thymidine for 30 minutes, and the percentage of labeled metaphases was scored each hour for 24 hours. Briefly, 1.75 X lo5 cells per 60-mm culture dish were seeded in a-MEM plus 10% FCS. Two days later, cultures were labeled for 30 minutes with ' H thymidine (1 mCi/mL, 80 Ci/mmol: Amersham), washed twice with culture medium, and then incubated in fresh medium supplemented with unlabeled thymidine (100 mmol/L). At each time point, cells were collected and immediately fixed by exposure to methanol and acetic acid (3: 1, vol/vol). Slides containing fixed cells were air-dried and dipped in NTB2 Kodak emulsion as described by the manufacturer (Kodak, Mame la VallCe, France). Dipped slides were air-dried, stored at 4°C for 3 weeks, and then developed and stained with Giemsa. One hundred metaphases were examined at each time point. The percentages of labeled metaphases were plotted versus time for each cell line studied. The time required to obtain SO% labeled metaphases is equivalent to the duration of G2 + M phase."
Analysis of Cell-Cycle Distribution Exponentially growing cells were obtained by trypsinisation, pelleted, and resuspended at a concentration of S X 10' cells per mL in 0.15 mom NaCl, 0.1 mol/L Tris HCI pH 7.6, then diluted with 20 vol of 0.1% (wt/vol) Na citrate, pH 7.6, 10 mmol/L NaCI, SO mg/mL RNase A, 0.1% NP40, and 10 mg/mL propidium iodide. The cells were then incubated at 4°C for 2 hours before flow cytometric analysis (Epics C; Coultronics, Margency, France).
RESULTS
Characterization of NIH 3T3 Cell Clones Obtained After Infection With a Recombinant Retrovirus Encoding Human GATA-1
The pBT Zen hGATA-1 SVNeo was constructed from pBT Zen SVNeo (FiglA) by inserting a 1.5-kb DNA fragment containing the hGATA-I coding sequence. pBT Zen hGATA-1 SVNeo and pBT Zen SVNeo were transfected into the Gp+E 86 packaging cell line. After 4 weeks in the presence of (3418, only one clone, designated Gp+E hGATA-1, developed from the cells transfected with the pBT Zen hGATA-1 SVNeo construct. In contrast, more than 500 clones were visible 2 weeks after transfection with the control pBT Zen SVNeo construct (Gp+E Neo clones).
GP+E hGATA-1 and Gp+E Neo cells were tested for their capacity to produce infectious retroviruses by infection of NIH 3T3 cells. The viral titers were 1.2 X lo3 and 5 X lo5 infectious particledml for the Gp+E hGATA-1 and Gp+E Neo cell culture supernatants, respectively. Southern blotting was used to examine the retroviral insertion sites in four NIWhGATA-I clones and four NIWNeo clones. Genomic DNA was digested with BglII and subjected to Southem blot analysis with a Neo probe (FigIB). Two bands were detected for each NIHhGATA-1 clone (lanes 7 to 10). The lower band, common to all the samples, corresponded to the expected 2.2-kb retroviral internal fragment, indicating that these clones had no major rearrangement of the integrated provirus. The upper band corresponded to the 3' proviral junction fragment. Its size was different in the four samples, demonstrating that these clones had arisen from independent infectious events. The hGATA-1 virusproducing cell line (Fig lB, lane 6 ) also exhibited the expected 2.2-kb internal fragment. Three other bands were shown by the Neo probe and corresponded to three different integration sites of the transfected retroviral construct. Analysis of four NIWNeo clones also showed a common band of 1.1 kb (Fig IB, lanes 2 to 5) , corresponding to the internal BgZII fragment in the retroviral construct. Each infected Neo clone exhibited another band, which differed in size for each clone, and corresponded to the 3' proviral junction fragment. The I . 1-kb internal BglII fragment was present in the Gp+E Neo producer clone (Fig lB, lane I) , together with three other bands that corresponded to three separate integration sites of the transfected retroviral construct. These results demonstrated that the selected hGATA-I and Neo clones arose from independent infectious events and did not have rearranged integrated provirus. These clones were used for further studies.
Proviral expression in the infected NIH3T3 clones and in the producing cell lines was studied by Northern blot analysis using a Neo probe. For each sample, two bands were detected (Fig IC) . The larger one corresponded to the genomic proviral RNA (5.1 kb for the hGATA-I virus, lanes 6 to 10; and 3.6 kb for the Neo virus, lanes 1 to 5), whereas the smaller band (2 kb) corresponded to the neomycin resistance-encoding mRNA, starting from the SV40 internal promoter. The size of this band was identical for both constructs (see Fig 1A) . This Northem blot showed that all the selected NIHhGATA-1 and NIH/Neo clones expressed high levels of proviral mRNAs.
The expression of GATA-1 was further examined at the protein level by electrophoretic mobility shift and super-shift assays of nuclear extracts of the NIHhGATA-1 or NIWNeo cells (FiglD, left) . For this assay, a sequence present in the erythroid PBGD gene promoter, which is known to bind GATA proteins," was used, while for the super-shift assays, an anti-hGATA-1 antibody was employed. As shown in Fig  lD, specific complexes of various intensities were obtained not only from the NIWhGATA-1 but also from the NIH/ Neo clone. In this latter clone, the complex was not related to the expression of endogenous murine GATA-1, GATA-2, or GATA-3, as mRNAs encoding these proteins were undetectable by Northern blot analysis (data not shown).
Super-shift experiments indicated that the hGATA-1 protein was produced only in the NIWhGATA-1 clones. The nuclear extract for NIHhGATA-1 clone I contained less protein than the other nuclear extracts, explaining why the complex and the supershift were less obvious. Subsequently, we com-
the amount of hGATA-I protein present in NIH/ hGATA-I cells to the amount present in UT-7 cells, a human leukemic cell line having erythroid features.IX By means of an electrophoretic mobility shift assay, we found that the amount of hGATA-I protein is roughly the same in both UT-7 and NIH/hGATA-I cells (Fig ID, right) .
Finally, we examined the transactivating properties of the hGATA-I protein stably produced in the hGATA-I virusproducing cells (Gp+E hGATA-I). To that end, we transiently transfected a reporter gene construct encoding CAT driven by the GATA-I transactivable glycophorin B promoter into these cells.'9 The CAT activity was reproducibly increased twofold in the hGATA-I virus-producing cell line compared to either the same producing cell line transfected with a reporter plasmid mutated in the GATA binding site of the glycophorin B promoter''' or the control cell line (the Neo virus-producing cell line, Gp+E Neo) transfected with either of these two constructs. This indicated that hGATA-1 had transactivated the normal glycophorin B promoter (Fig  1 E) .
These experiments showed that the hGATA-I protein, encoded by the integrated recombinant provirus, was produced in the selected NIH/hGATA-I cell clones or Gp+E hGATA-I-producing cell line as a biologically active protein, involved in both DNA binding and transactivation.
Constitutive Expression of hGATA-1 in NIH3T3 Cells
Fails to Induce the Transactivation of Erythroid-
Specific Genes
Expression of erythroid-specific mRNAs, ie, the erythropoietin receptor (Epo-R), erythrocytic porphobilinogen deaminase (PBGDe), major 0-globin, or the endogenous GATA-I was not detected in fibroblasts expressing hGATA-1 either by Northern blot or by reverse transcriptase-polymerase chain reaction (RT-PCR) (data not shown). This indicated that GATA-I alone was unable to transactivate its putative target genes in fibroblastic cells.
Constitutive Expression of hGATA-1 Interferes With the Growth Rate But Not With the Cloning Efficiency of NIH3T3 cells
Two preliminary observations suggested that hGATA-1 interfered with NIH3T3 cell proliferation: ( I ) the low number of clones obtained either after transfection of the construct in the packaging cell line or after infection of NIH3T3 cells with the hGATA-I virus; and (2) the difficulties in amplification of NIH/hGATA-I cells in comparison to NIH/ Neo cells.
To investigate these phenomena, we first assessed the cloning efficiency of infected NIH3T3 cells in their usual culture medium. Figure 2 is a photograph of the clones developing from 500 NIH/hGATA-I or NIH/Neo cells seeded per Petri dish 12 days earlier. NIH/hGATA-I cell colonies were much smaller than the NIH/Neo cell clones, and were barely visible at day 12 (Fig 2, 10% serum) . The maintenance of duplicate cultures up to day 19 permitted the NIH/hGATA-I cell colonies to become easily visible and enumerable. No difference in the plating efficiencies of NIH/hGATA-1 cells and NIHMeo cells was observed; however, it appeared that the NIH/hGATA-I cells had a slower growth rate than NIH/Neo cells. Increasing serum concentration in these cloning experiments had a slight but noticeable effect on the size of the NIHIhGATA-1 colonies, with a maximal effect observed at 20% serum (Fig 2, 20% and 30% serum) . A similar effect was noted with NIH/Neo colonies, indicating that the low proliferative capacity of NIH/hGATA-1 cells cannot be related to a decreased sensitivity to serum growth factors.
Because a potential explanation for the lower growth rate of the NIHhGATA-1 cells could be premature apoptosis, DNA was prepared from a population of cells in exponential growth. No DNA laddering was observed (Fig 3) . Furthermore, no chromatin fragmentation was noted when the cells were examined at different densities by phase-contrast microscopy at high magnitude (not shown). Thus, apoptosis could not explain the decreased growth rate of NlHhGATA-1 cells compared with NIH/Neo cells. Therefore, we next investigated if hGATA-I modifies the cell cycle. (Fig 4A) .
To investigate if the cell-cycle phases were altered in the NIWhGATA-1 cells, we first determined the S-phase length using a graphic method based on continuous BrdUdr labeling.I6 At low cell density, the slopes of the NIWhGATA-1 and the " eo cell curves were very different (Fig 4B) , confirming the growth rate reduction of NIHhGATA-1 cells when compared with the control. Duration of S phase in the NIHhGATA-1 and the NIWNeo cells were 26 hours and 9 hours, respectively. At high cell concentration, the slopes of the two curves were similar, confirming that the growth rates were similar for NIWNeo and NIWhGATA-I cells. However, the difference in the length of S phase of the NIW hGATA-1 and the NIWNeo cells was maintained (22 hours v 12 hours 30 minutes). We next measured the length of the G2/M phase by using the labeled mitosis m e t h~d . '~ This determination was only performed at high cell density because at least 100 metaphases per time point must be scored. As shown in Fig 4C, the length of the G2/M phase was 2 hours 30 minutes for NIHhGATA-1 cells and 6 hours 30 minutes for NIH/Neo cells. The length of the GI phase at high cell density, deduced from the doubling times and the length of the S and G2/M phases, was 6 hours 30 minutes and 10 hours 30 minutes for the NIHhGATA-I and the NIWNeo cells, respectively. These data are summarized in Table 1 .
NIH/hGATA-1 Cells Continue to Enter S Phase Even at Low Serum Concentrations
The cellular distribution of the cell-cycle phases was studied in two NIHhGATA-I and two NIH/Neo cell clones, first after serum starvation (0.5% serum) for 48 hours and at different times after subsequent stimulation by 10% serum supplementation. After 48 hours in 0.5% serum, 65% of NIH/hGATA-1 cells were in GO/GI phase, while 80% of NIH/Neo cells were in GO/Gl phase (Fig 4,  t = 0) . After 6 hours of restimulation by 10% serum, there was no change in the cellular distribution of the cell cycle phases, either for NIHhGATA-1 or for NIHMeo cells (Fig 5, t = 6 hours) . However, after 12 hours, there was a dramatic entrance of NIHMeo cells into S phase, whereas the cell-cycle distribution of NIHhGATA-1 cells was not substantially changed (Fig 5, t = 12 hours) . This effect was particularly marked for clone 4 (Fig 5D, t = 12 hours). At this time point, it was not possible to precisely quantitate the proportion of cells in each cell-cycle phase because their distribution profiles did not fit the available models. Thirty hours after serum stimulation, the distribution of NIHhGATA-1 cells retumed to the usual distribution of cells grown in 10% serum, whereas NIH/Neo cells were predominantly in the S and G2/M phases (Fig 5, t  = 30 hours) . This experiment showed that the NIH/ hGATA-1 cells were poorly responsive to both serum starvation and to serum restimulation. However, NIH/ hGATA-I cells were not serum independent because prolonged serum deprivation led to an arrest of proliferation and to cell death, albeit delayed when compared with NIH/ Neo cells.
hGATA-I Expression Results in Cyclin mRNA Accumulation in Cells Cultivated at Low Serum Concentration or at Confluence
The perturbations observed in the cell cycle of NIW hGATA-1 cells as well as their failure to accumulate in GO/ GI after 48 hours of serum starvation were reminiscent of the changes described in fibroblasts transfected with expression plasmids encoding cyclin D120-22 or cyclin E.I7 Thus, the expression of cyclins D1, A, and B 1 was studied by successive hybridization of the same Northern blots. RNA was prepared from NIWNeo and NIWhGATA-1 cells in exponential growth (Fig 6, lanes l) , from cells confluent for 24 hours (Fig 6, lanes 2) . and from cells grown to 50% confluence in the usual culture medium and subsequently serumstarved (0.5% serum) for 48 hours (Fig 6, lanes 3) . (Fig 6B) showed no difference in mRNA levels between exponentially growing NWhGATA-1 and NIWNeo cells (compare the lanes designated 1). Confluence of cells for 24 hours resulted in a substantial decrease in cyclin D1 mRNA levels in NIIUNeo cells, whereas no change was observed in NIHhGATA-1 cells (compare the lanes designated 2). After 48 hours of serum starvation, the cyclin D1 mRNA level was maintained in NWhGATA-1 cells, whereas it was greatly decreased in NIWNeo cells (compare the lanes designated 3).
When the Northern blot was hybridized with the cyclin A probe (Fig 6C) , the amount of cyclin A mRNA was identical for exponentially growing NIHhGATA-1 and " eo cells (lanes 1). When cells were maintained at confluence for 24 hours, the level of cyclin A mRNA was slightly decreased in NIHhGATA-l cells but greatly decreased in NIW Neo cells (lanes 2). In the serum-starved NIHhGATA-1 The doubling time was calculated from the MTT data, the length of S phase was graphically deduced from BrdUdr labeling data, and the length of G2/M phase was obtained by the labeled mitosis method. The length of G I phase was calculated from the other experimental data.
Abbreviation: ND, not determined.
cells, cyclin A expression was lower than in cells grown in 10% serum. In contrast, no cyclin A mRNA was detectable in serum-starved NIH/Neo cells (lanes 3). Finally, Fig 6D shows that cyclin B1 mRNA was present in equal amounts in exponentially growing NIH/hGATA-1 and NIH/Neo cells (lanes 1). In confluent NIH/Neo cells, cyclin B1 mRNA was not detected while it was abundant in NIHhGATA-1 cells (lanes 2). In serum-starved NIWNeo cells, mRNA for cyclin B1 was barely detectable, whereas it was only slightly decreased in NIHhGATA-1 cells compared with the corresponding exponentially growing cells (lanes 3).
hGATA-1 Expression Also impairs the Proliferation of FDCP-1 Cells, a Murine IL-3-Dependent Hematopoietic Cell Line
To show that the effect of hGATA-1 expression on cell proliferation was not limited to NIH3T3 fibroblasts, we also infected the FDCP-1 cell line and derived several G418-resistant clones. Growth curves were established for these clones as well as for the parental cell line and a Neo virus infected clone (Fig 7) . From these curves we calculated that the doubling time of the control cells was approximately 12 hours while the doubling time of the hGATA-1 virus-infected clones was between 17 and 22 hours, depending on the clone examined.
DISCUSSION
We have produced recombinant retroviruses that resulted in the production of the hGATA-l protein and studied the effects of hGATA-1 expression on NIH3T3 cells. As GATA-1 seems to be a master gene of the erythroid differentiation pathway,23 we first looked for erythroid gene activation in the hGATA-1 expressing fibroblasts. However, Northern blots or RT-PCR did not detect any expression of erythroidspecific genes in NIWhGATA-1 cells. Thus, in contrast to the members of the MyoD family which transactivate muscle gene markers in NIH 3T3 cells," GATA-1 is unable to transactivate its putative target genes in this cell line. Two hypotheses can be made to explain the lack of transactivation by GATA-1: (1) in NIH3T3 cells, the erythroid genes are com-DUBART ET AL pacted in inactive chromatin and are not accessible to transacting factors; and (2) GATA-l by itself is not able to transactivate the erythroid genes. As globin and GATA-1 genes are activated in nonerythroid nuclei of transient heterokaryons obtained from erythroid and nonerythroid cells,25 our results suggest that GATA-1 must synergize with other transactivating factors present in the nuclei of erythroid cells, but absent in NIH3T3 cells, to activate erythroid-specific genes. In contrast, GATA-1 had a major effect on the proliferation of NIH 3T3 cells. The doubling time of hGATA-1 -expressing fibroblasts grown at low cell density was 1.5 times longer than in control cells, indicating that ectopic expression of hGATA-1 had a major effect on the proliferative properties of fibroblasts. This result explains the differences in hGATA-1 and Neo fibroblast clone size. Cloning experiments either in 10% serum or in increased serum concentrations showed that the prolonged doubling time of NIHhGATA-1 cells grown at low cell density was related neither to a decreased cloning efficiency nor to a deficient response to exogenous growth factors. Premature apoptosis could not account for this prolonged doubling time of NIHhGATA-1 cells grown
B r l mL I K l G2IM 8 G2IM 8 G Z M 37 cKl rl mru at low cell density since no DNA or chromatin fragmentation could be observed in NIHhGATA-I cells. In contrast to the observations made at low cell density, NIHhGATA-I cells grown at high cell concentration had the same growth rate as NIH/Neo cells. This difference between low and high cell-density growth rates is highly evocative of autocrine stimulation; however, we could not identify such a mechanism using cloning experiments in the presence of conditioned media from subconfluent NIHhGATA-1 or NIH/Neo cell cultures (data not shown). The secretion of an inhibitor by the diluted NIHhGATA-I cells is also unlikely because the conditioned medium of these cells did not inhibit the proliferation of NIH/Neo cells. The lower growth rate of NIHhGATA-I at low cell density compared with high cell density could also result from the requirement of cellcell contact involving adhesion molecules or extracellular matrix-bound growth factors. However, to our knowledge, such a mechanism has never been described in fibroblasts. This increased doubling time of the NIHhGATA-I cells was accompanied by a prolongation of S phase, which was much more pronounced when cells were sparse than when cells were subconfluent. At high cell density, the G2/M and the G 1 phases of the NIHhGATA-1 cells were shortened, For personal use only. on October 22, 2017. by guest www.bloodjournal.org From resulting in a doubling time identical to that of control cells. Thus, the effect of hGATA-1 on cell cycle regulation of NIHhGATA-1 cells could be summarized as a prolonged S phase associated with facilitated progression through the two restriction points of the cell cycle: G I to S and G2 to M. To investigate these phenomena, we examined the expression of cyclins since they play an important role in cell-cycle progression and are regulated at the transcriptional level. 16 Furthermore, overexpression of cyclin D1 in fibroblasts has been hypothesized to deregulate the cell cycle, leading to a shortened GI phase and a prolonged S phase.*' Evidence exists that Cyclin A mRNA accumulates shortly before Sphase entry, and it has been suggested that it promotes the Gl/S transition." Cyclin B1 is the most important regulator of G2 to M phase transition.z8 However, we could not demonstrate a direct effect of GATA-1 on the expression of these cyclins. Indeed, in exponentially growing NIH/hGATA-1 cells, no overexpression of cyclins D1, A, or B1 mRNAs was observed. Furthermore, preliminary experiments showed that the cyclin D l promoter is not transactivated by GATA-1 (D. Lawe, personal communication, April 1995). Nevertheless, in contrast with NIWNeo cells which accumulated in GO with a low level of cyclin D1 gene transcription, NIH/ hGATA-I cells still exhibited a high level of cyclin D1 mRNA both after 48 hours in 0.5% serum and at confluence. Similar results were found with cyclin A and cyclin B1 gene transcripts. Therefore, it seems likely that this accumulation of cyclin D1, A, and B1 mRNAs by NIHhGATA-1, grown in 0.5% serum or at confluence for 48 hours, was a consequence rather than the cause of the abnormal cell cycle, because expression of cyclins are not deregulated in exponentially growing NIHhGATA-1 cells.
NIHhGATA-1 cells were less sensitive to serum starvation than were NIH/Neo cells. The former cell line entered S phase after 48 hours in 0.5% serum, whereas under the same conditions NIH/Neo cells were blocked in GO/Gl. In these serum-deprived conditions, NIH/hGATA-1 did not proliferate and died just as control cells, but in a significantly delayed manner. We conclude that ectopic expression of hGATA-1 did not induce serum independence in NIH3T3 cells, but could transiently block apoptosis. This hypothesis of an anti-apoptotic role of GATA-I is strengthened by the recent publication by Weiss and OrkinZ9 who observed that GATA-1 --embryonic stem cells undergo apoptosis during erythroid differentiation, even in the presence of high amounts of GATA-2. Other DNA-binding proteins, ectopically expressed in fibroblasts, as it is the case here for GATA-I, may also interfere with the cell-cycle regulation. Interestingly, the effects of GATA-1 expression on the cell cycle are not restricted to fibroblasts. Indeed, this impaired proliferation induced by GATA-1 was also observed in the hematopoietic cell line FDCP-1. This observation is reminiscent of the loss of proliferative capacity during terminal erythroid differentiation."'3' Thus, we suggest that GATA-1 not only controls the expression of erythroid-specific proteins, but also regulates the cell cycle during terminal erythroid differentiation. Similarly, in the megakaryocytic cell lineage, where GATA-I is also expressed and regulates megakaryocyte-specific gene expression,' there is a temporal correlation between the beginning of expression of these proteins and a change in proliferation, marked by a switch from mitosis to endomitosis. In conclusion, GATA-I may play an important role in the regulation of the cell cycle by a mechanism that remains to be understood.
